Advertisement
Australia markets closed
  • ALL ORDS

    7,898.90
    +37.90 (+0.48%)
     
  • AUD/USD

    0.6445
    +0.0008 (+0.12%)
     
  • ASX 200

    7,642.10
    +36.50 (+0.48%)
     
  • OIL

    82.28
    -0.41 (-0.50%)
     
  • GOLD

    2,399.40
    +11.00 (+0.46%)
     
  • Bitcoin AUD

    96,932.80
    -555.34 (-0.57%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Why Novocure Stock Was so Healthy Today

Why Novocure Stock Was so Healthy Today

In the biotech world, investors often heave a sigh of relief when an important clinical goal is met. Novocure announced that it has completed enrollment in its upcoming Panova-3 study of its Tumor Treating Fields product (TTFields). The clinical trial will gauge the efficacy of TTFields when administered in combination with chemotherapy treatments nabpaclitaxel and gemcitabine to fight locally advanced pancreatic cancer.